Literature DB >> 31062638

Blindness and Visual Impairment in the Medicare Population: Disparities and Association with Hip Fracture and Neuropsychiatric Outcomes.

Ali G Hamedani1, Brian L VanderBeek2,3, Allison W Willis1,3.   

Abstract

Purpose: Vision loss has been associated with negative health outcomes, but population-level data on vision loss are lacking, and there are limited data on low vision-associated outcomes among women, minorities, and older age groups. The objective of this study was to determine the prevalence of vision loss in a nationally representative sample of older US adults and examine its association with hip fracture, depression, anxiety, and dementia.
Methods: Cross-sectional analysis of Medicare claims data from 2014. Blindness and low vision, hip fracture, depression, anxiety, and dementia were identified using Chronic Condition Warehouse indicator variables based on ICD-9 and CPT codes. Multivariable logistic regression models were built to examine whether sociodemographic factors were associated with vision loss and to determine the relationships between vision loss and hip fracture and neuropsychiatric outcomes.
Results: The prevalence of low vision in the Medicare population was 994/100,000 and increased significantly with age, Black (1,854/100,000) or Hispanic (2,862/100,000) race/ethnicity, female gender (1,181/100,000), and Medicaid eligibility (2,975/100,000). After adjusting for relevant comorbidities, low vision was significantly associated with hip fracture (adjusted odds ratio [AOR] 2.54, 95% CI: 2.52-2.57), depression (AOR 3.99, 95% CI: 3.97-4.01), anxiety (AOR 2.93, 95% CI: 2.91-2.95), and dementia (AOR 3.91, 95% CI: 3.88-3.93).
Conclusion: Blindness and low vision are common in older Americans, especially among racial and ethnic minorities and lower income individuals, and associated with hip fracture, depression, anxiety, and dementia. The prevention and treatment of vision loss may reduce health disparities and negative health outcomes in the aging population.

Entities:  

Keywords:  Blindness; dementia; health disparities; hip fracture; vision loss

Mesh:

Year:  2019        PMID: 31062638      PMCID: PMC6641987          DOI: 10.1080/09286586.2019.1611879

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  43 in total

Review 1.  Glaucoma as a neurodegenerative disease.

Authors:  Helen V Danesh-Meyer; Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2015-09       Impact factor: 3.042

2.  Vision and quality-of-life.

Authors:  G C Brown
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma.

Authors:  Alberto Diniz-Filho; Ricardo Y Abe; Hyong Jin Cho; Saif Baig; Carolina P B Gracitelli; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2016-02-23       Impact factor: 12.079

4.  Impaired vision and hip fracture. The Framingham Study.

Authors:  D T Felson; J J Anderson; M T Hannan; R C Milton; P W Wilson; D P Kiel
Journal:  J Am Geriatr Soc       Date:  1989-06       Impact factor: 5.562

5.  Association of Vision Loss With Cognition in Older Adults.

Authors:  Stephanie P Chen; Jay Bhattacharya; Suzann Pershing
Journal:  JAMA Ophthalmol       Date:  2017-09-01       Impact factor: 7.389

Review 6.  Disparities in adult vision health in the United States.

Authors:  April Zambelli-Weiner; John E Crews; David S Friedman
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

7.  Untreated poor vision: a contributing factor to late-life dementia.

Authors:  Mary A M Rogers; Kenneth M Langa
Journal:  Am J Epidemiol       Date:  2010-02-11       Impact factor: 4.897

8.  Prevalence and predictors of depression among participants with glaucoma in a nationally representative population sample.

Authors:  Sophia Y Wang; Kuldev Singh; Shan C Lin
Journal:  Am J Ophthalmol       Date:  2012-07-11       Impact factor: 5.258

9.  Diabetic retinopathy in a multi-ethnic cohort in the United States.

Authors:  Tien Yin Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; Aaron R Folsom; Barbara E K Klein; A Richey Sharrett; Steven Shea
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

10.  Disparities in delivery of ophthalmic care; An exploration of public Medicare data.

Authors:  Cecilia S Lee; Grace L Su; Douglas M Baughman; Yue Wu; Aaron Y Lee
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

View more
  8 in total

1.  Self-reported visual dysfunction in Parkinson disease: the Survey of Health, Ageing and Retirement in Europe.

Authors:  A G Hamedani; A W Willis
Journal:  Eur J Neurol       Date:  2019-10-19       Impact factor: 6.089

2.  The Cost-Effectiveness of a Telemedicine Screening Program for Diabetic Retinopathy in New York City.

Authors:  Hasan Muqri; Anurag Shrivastava; Rakin Muhtadi; Roy S Chuck; Umar K Mian
Journal:  Clin Ophthalmol       Date:  2022-05-17

Review 3.  The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies.

Authors:  Gianni Virgili; Mariacristina Parravano; Davide Petri; Erica Maurutto; Francesca Menchini; Paolo Lanzetta; Monica Varano; Silvio Paolo Mariotti; Antonio Cherubini; Ersilia Lucenteforte
Journal:  J Clin Med       Date:  2022-04-25       Impact factor: 4.964

4.  Low rates of eye care utilization among visually impaired subsidized senior housing residents.

Authors:  Amanda F Elliott; Megan Heskett; Christopher Spiker; Gerald McGwin; Cynthia Owsley
Journal:  Aging Ment Health       Date:  2019-11-07       Impact factor: 3.658

5.  Vision impairment and cognitive decline among older adults: a systematic review.

Authors:  Niranjani Nagarajan; Lama Assi; V Varadaraj; Mina Motaghi; Yi Sun; Elizabeth Couser; Joshua R Ehrlich; Heather Whitson; Bonnielin K Swenor
Journal:  BMJ Open       Date:  2022-01-06       Impact factor: 3.006

6.  Hip Fractures and Visual Impairment: Is There a Cause-Consequence Mechanism?

Authors:  Gianluca Testa; Sara De Salvo; Silvia Boscaglia; Marco Montemagno; Antonio Longo; Andrea Russo; Giuseppe Sessa; Vito Pavone
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

7.  Geospatial analysis of blindness within rural and urban counties.

Authors:  Facundo G Sanchez; Stuart K Gardiner; Shaban Demirel; Jack P Rees; Steven L Mansberger
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

8.  Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial.

Authors:  Assaf Gershoni; Alon Tiosano; Meydan Ben Ishai; Edward Barayev; Guy J Ben Simon; Iftach Yassur
Journal:  Eye (Lond)       Date:  2021-03-10       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.